[EN] LOW CELL TOXICITY ANTIBIOTIC HYGROMYCIN B<br/>[FR] HYGROMYCINE B ANTIBIOTIQUE PRÉSENTANT UNE FAIBLE TOXICITÉ CELLULAIRE
申请人:TOKU E COMPANY
公开号:WO2012122282A1
公开(公告)日:2012-09-13
A preparation of antibiotic hygromycin B with low cell toxicity and high purity, and methods of preparing such a preparation, are provided. More specifically, an isolated antibiotic hygromycin B with a purity of greater than 98% and impurities C, D and E individually less than 0.5% and impurity F less than 2%, as measured by HPLC, is described. Uses of this high purity antibiotic hygromycin B include, for example, for in vitro cell selection.